Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PAROXETINE HYDROCHLORIDE
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial
- Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
- High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
- Management of Acute Tinnitus With Migraine Medications
- Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause
- Silexan in the Treatment of Posttraumatic Stress Disorder Trial
- Cangpo Liujun Prescription on Cancer-related Fatigue in Advanced Colorectal Cancer With Spleen Deficiency and Dampness Excess
- Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects
- Paroxetine Safety and Efficacy in Rheumatoid Arthritis
- The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
- Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer
- Concentration-QT Study of Paroxetine in Healthy Adults
- Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
- Influence of Oxycodone on Individuals Taking an SSRI
- Effects of Paroxetine on Cardiovascular Function in Septic Patients
- Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
- Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation
- Measurement-Based Care Vs. Standard Care for Major Depressive Disorder
- Cariprazine Versus Placebo for Social Anxiety Disorder
- Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder
- Postpartum MDMA Co-occurring PTSD and OUD
- EEG Results of Deep TMS in Patients With OCD
- Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects
- Impact of Silymarin Dosages to Decrease Drug-induced Elevated Liver Enzymes Compared to Placebo
- A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants
- A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
- To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
- The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients
- Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects
- Sequenced Treatment Effectiveness for Posttraumatic Stress
- Treatment of Tinnitus With Migraine Medications
- Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants
- Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
- Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation
- Endobiotics for Phenotyping of Human Cytochrome P450 Enzymes
- Vortioxetine for the Treatment of Hoarding Disorder
- Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment
- Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
- Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers
- Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects
- Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
- Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders
- Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction
- Hot Flash as a Marker of Cardiovascular Risk in Recent Postmenopause: Effects of Non-hormonal Treatments
- Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6
- Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
- Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy Volunteers
- Stellate Ganglion Blockade in Post-Menopausal Women
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine
- Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
- Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers
- A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity
- Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
- Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
- Newer Antidepressants in Combination With Pregabalin for Fibromyalgia Syndrome
- Pharmacovigilance in Gerontopsychiatric Patients
- Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
- Intervention Study for Individuals With Compulsive Sexual Behavior
- The Gut Microbiota in Obsessive-Compulsive Disorder
- Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder
- Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
- Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers
- Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
- The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial
- A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects
- Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Neurobiology of Eating Disorders Treatments
- Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
- Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
- Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
- Interpersonal Psychotherapy for Treatment Resistant Depression
- Interaction Between Paroxetine and Telaprevir
- Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women
- Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
- Algorithm Guided Treatment Strategies for Major Depressive Disorder
- Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study
- Ketamine in the Treatment of Suicidal Depression
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
- Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
- Vilazodone for Treatment of Geriatric Depression
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
- Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement
- Lithium Versus Paroxetine in Major Depression
- Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
- Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)
- Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
- Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
- Special Drug Use Investigation for PAXIL Tablet (Long-term)
- Drug Use Investigation for PAXIL Tablet
- Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
- Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
- Paxil CR Bioequivalence Study Brazil - Fed Administration
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine
- Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects
- Paxil CR Bioequivalence Study Brazil
- Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
- Lexapro for Major Depression in Patients With Epilepsy
- Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
- A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers
- An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands
- Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack
- 24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
- Amitriptyline and Paroxetine Treatment of Major Depression
- Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation
- Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects
- Trial of Aripiprazole in Trichotillomania
- Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
- Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
- Lamotrigine Augmentation in Resistant Depression
- Interaction Study of Timolol Eye Drops and Paroxetine Capsules
- Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
- Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions
- Paroxetine Hydrochloride 40 mg Tablets Under Fed Conditions
- BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
- Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
- Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine
- Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine
- Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
- A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
- Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
- Paroxetines Effect on Tramadols Metabolism and Pharmakodynamics: a Dose Response Study
- Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder
- PAXIL CR Bioequivalence Study
- Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
- Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
- Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder
- Brain Markers of Treatment Response in Post-Traumatic Stress Disorder (PTSD)
- A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder
- Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)
- A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
- Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)
- Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
- A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
- Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation
- Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
- Fasting Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
- Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg
- Food Study of Paroxetine Hydrochloride Controlled-Release Tablets 25 mg to Paxil CR™ Tablets 25 mg
- Early Intervention for Post Traumatic Stress Disorder (PTSD)
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
- Luteal Phase Administration of Paroxetine for the Treatment of PMDD
- Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
- Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
- Dementia Antipsychotics And Antidepressants Discontinuation Study
- Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
- Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder
- Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)
- Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder (PTSD)
- Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
- Benefits of Switching Antidepressants Following Early Nonresponse
- Duloxetine for Perimenopausal Depression
- Omacor for Perimenopausal Depression
- A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria
- Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release
- Duloxetine Versus Paroxetine for Major Depression
- A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
- A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
- Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway
- AV650 Drug-Drug Interaction Study
- A Placebo-Controlled Study of Mirtazapine for PTSD
- Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
- The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder
- Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
- MDD POC Study GSK372475 Subjects Depressive Disease
- Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
- A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
- A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects
- Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
- A Combination Therapy In Patients With Social Anxiety Disorder
- Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities
- Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
- Treatment Of Patients With Social Anxiety Disorder
- Antidepressant Safety in Kids Study
- Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
- SSRI Effects on Semen Parameters in Men
- Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)
- Clinical Pharmacogenomics of Antidepressant Response
- An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder
- A Local Register Study For Major Depression Of Paroxetine Controlled Release
- An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
- Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
- PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
- Naltrexone & SSRI in Alcoholics With Depression/PTSD
- Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
- Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
- Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
- Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
- Nicotinic Receptor Augmentation of SSRI Antidepressants
- Social Anxiety Disorder Study Of Paroxetine
- A Placebo-Controlled Study of Mirtazapine for PTSD
- Quetiapine Augmentation for Treatment-resistant PTSD
- Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Management of MS-induced Neuropathic Pain
- A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
- Patient-Centered Collaborative Care for Preventing Post-Traumatic Stress Disorder After Traumatic Injury
- Clinical Pharmacogenomics of Antidepressant Response
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
- Long-term Study Of Paroxetine in Women and Men
- Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
- Combination Of PAXIL Tablet And Benzodiazepines
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
- Study of PET Scans and Serotonin in Hot Flashes Treatment
- Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
- Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
- Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain
- Study of Paxil Use in Menopausal Women
- Effect of Paroxetine on Smokers' Cardiovascular Response to Stress - 1
- Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy
- Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
- Geodon (Ziprasidone) for Posttraumatic Stress Disorder
- Risperidone vs. Paroxetine for Panic Attacks
- Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin
- Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder
- Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
- Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response
- RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
- Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
- Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression
- Paroxetine in the Treatment of Chronic Primary Insomnia
- Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals
- Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study
- Aripiprazole as Augmentation for TRD
- Phenytoin as an Augmentation for SSRI Failures
- Comparing Paroxetine and Duloxetine on Cardiovascular Measures
- Study Of Generalized Anxiety Disorder
- Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment
- Trial of Paroxetine-CR for the Treatment of Patients With Post Traumatic Stress Disorder Remaining Symptomatic After Initial Exposure Therapy
- Seroquel in Bipolar Depression Versus SSRI
- Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
- Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
- Chronic Low Back Pain Research Project
- Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance
- Serotonin and the Upper Airway in Obstructive Sleep Apnea
- Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
- Study of Antidepressants in Parkinson's Disease
- Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
- Depression Study In Elderly Patients
- Treatment of Depression in Parkinson's Disease Trial
- Major Depressive Disorder Study In Adults
- A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
- Brain Receptor Function in Post-Traumatic Stress Disorder
- Study Evaluating Venlafaxine ER in Patients With Panic Disorder
- St. John's Wort Versus Placebo in Social Phobia
- Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
- Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
- Clonazepam and Paroxetine for Rapid Treatment of Post-Traumatic Stress Disorder
- Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients
- Biological Aspects of Depression and Antidepressant Drugs
- Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
- Treatment of Panic Disorder: Long Term Strategies
Clinical trials list
click for details